What is Montara Therapeutics worth?
$55.0Mlast known valuation
Montara Therapeutics last raised $20.0M in its Early Stage VC (Feb 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Montara Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2025 | Early Stage VC | $20.0M | ▮ | ▮ |
| Jan 2024 | Early Stage VC | $8.0M | ▮ | ▮ |
How Montara Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Montara Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Montara Therapeutics worth?
- Montara Therapeutics's last known valuation is $55.0M.
- How much has Montara Therapeutics raised?
- Montara Therapeutics has raised $28.0M in total funding across 2 recorded rounds.
- When did Montara Therapeutics last raise?
- Montara Therapeutics last raised in Feb 2025 (Early Stage VC), raising $20.0M.